RU94040720A - Antiprogestin estrogen (progestin), method of oral contraception and menstruation control, pharmaceutical composition and medicinal agents set - Google Patents

Antiprogestin estrogen (progestin), method of oral contraception and menstruation control, pharmaceutical composition and medicinal agents set

Info

Publication number
RU94040720A
RU94040720A RU94040720/14A RU94040720A RU94040720A RU 94040720 A RU94040720 A RU 94040720A RU 94040720/14 A RU94040720/14 A RU 94040720/14A RU 94040720 A RU94040720 A RU 94040720A RU 94040720 A RU94040720 A RU 94040720A
Authority
RU
Russia
Prior art keywords
antiprogestin
progestin
estrogen
menstruation
pharmaceutical composition
Prior art date
Application number
RU94040720/14A
Other languages
Russian (ru)
Other versions
RU2127112C1 (en
Inventor
Д.Ходген Гари
Us]
Хвалиш Кшиштоф
De]
Original Assignee
Шеринг АГ (DE)
Шеринг Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг АГ (DE), Шеринг Аг filed Critical Шеринг АГ (DE)
Priority claimed from PCT/US1993/001931 external-priority patent/WO1993017686A1/en
Publication of RU94040720A publication Critical patent/RU94040720A/en
Application granted granted Critical
Publication of RU2127112C1 publication Critical patent/RU2127112C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

FIELD: medicine, gynecology. SUBSTANCE: invention relates to menstruation regulation when pregnancy prevention is desirable that can be achieved at low doses of estrogen and progestin. The latters can make episodes of sudden bleeding and/or amenorrhea caused by drug withdrawal by periodic induction of menstruation with antiprogestin. EFFECT: enhanced effectiveness of method.

Claims (1)

Регулирование менструации и, когда желательно, предупреждение беременности достигается при малых дозах эстрогена и прогестина, которые иначе создавали бы эпизоды внезапного кровотечения и/или обусловленной отменой приема лекарства аменореи, посредством периодического вызывания менструации антипрогестином.The regulation of menstruation and, when desired, the prevention of pregnancy is achieved with small doses of estrogen and progestin, which would otherwise create episodes of sudden bleeding and / or amenorrhea caused by the withdrawal of the drug by periodically inducing menstruation with antiprogestin.
RU94040720/14A 1992-03-02 1992-03-02 Estrogen (progestin)-anitoprogestin method of peroral contraception and menstruation control, pharmaceutical composition, and assembly of drugs RU2127112C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84305892A 1992-03-02 1992-03-02
US07.843,058 1992-03-02
PCT/US1993/001931 WO1993017686A1 (en) 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Publications (2)

Publication Number Publication Date
RU94040720A true RU94040720A (en) 1997-05-27
RU2127112C1 RU2127112C1 (en) 1999-03-10

Family

ID=25288971

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94040720/14A RU2127112C1 (en) 1992-03-02 1992-03-02 Estrogen (progestin)-anitoprogestin method of peroral contraception and menstruation control, pharmaceutical composition, and assembly of drugs

Country Status (8)

Country Link
KR (1) KR100271750B1 (en)
CN (1) CN1395932A (en)
AT (1) ATE401083T1 (en)
DE (1) DE69334229D1 (en)
FI (1) FI20021041A (en)
MY (1) MY110528A (en)
RU (1) RU2127112C1 (en)
UA (1) UA77934C2 (en)

Also Published As

Publication number Publication date
RU2127112C1 (en) 1999-03-10
MY110528A (en) 1998-07-31
CN1395932A (en) 2003-02-12
UA77934C2 (en) 2007-02-15
DE69334229D1 (en) 2008-08-28
ATE401083T1 (en) 2008-08-15
FI20021041A (en) 2002-05-31
KR100271750B1 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
DE68928897D1 (en) METHOD AND SYSTEM FOR PREVENTION
CA2188907A1 (en) Combination compound for contraception based on natural estrogen
ATE216241T1 (en) VERY LOW DOSE ORAL CONTRACEPTIVE WITH LESS MENSTRUAL BLEEDING AND DELAYED EFFECT
LU90341I2 (en) 75 Ug desogestrel in the absence of ethinyl estradiol (cerazette)
YU49026B (en) THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
KR930001902A (en) Method for preparing fatty acid drug
KR970025615A (en) Cancer metastasis inhibitor
ES2055014T3 (en) PRODUCTS CONTAINING PSYLLIUM.
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
RU94040720A (en) Antiprogestin estrogen (progestin), method of oral contraception and menstruation control, pharmaceutical composition and medicinal agents set
KR930003924A (en) Treatment of bone wasting diseases
KR930019224A (en) Abortion Hazard Remedy
BR9814136A (en) Contraceptive set, manufacturing processes and bleeding treatment, uses of anti-progestin, progestin and anti-progestin, and a compound.
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate
KR960700726A (en) METHOD OF PREVENTING OF INHIBTING FERTILIZATION
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety
KR920016104A (en) Topical Use of Calcitonin for the Preparation of Idiopathic Idiopathic Cataract Drugs and Their Pharmaceutical Compositions
TH14144EX (en) Reduction of effusion of blood loss caused by the use of progestin.
ATE161542T1 (en) ORAL ESTROGEN ACTIVE ESTERS OF 14 ALPHA,15 ALPHA-METHYLENE-ESTRADIOL
KR890001567A (en) Diflunisal and Tromethamine-Containing Compositions
SU1711368A1 (en) Repellent
KR890002058A (en) 2,4,6-tris-3-tert-butylamino-1, -3, -5-triazine for the prevention and treatment of epilepsy and anxiety
TH14144A (en) Reduction of effusion of blood loss caused by the use of progestin.

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20070425

MM4A The patent is invalid due to non-payment of fees

Effective date: 20080303